glimepiride
Sign in to saveGlimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. Use of glimepiride is recommended in conjunction with lifestyle modifications such as diet and exercise. It is taken by mouth, reaching a peak effect within three hours and lasting for about a day.
Research
1,852 papers- Pioglitazone hydrochloride/glimepiride.Drugs of today (Barcelona, Spain : 1998) · 2007
- Glimepiride pharmacokinetics in overdose.Clinical toxicology (Philadelphia, Pa.) · 2022
- Glimepiride. A review of its use in the management of type 2 diabetes mellitus.Drugs · 1998
- [Glimepiride--an oral antidiabetic agent].Medicinski arhiv · 2003
- Clinical profile of glimepiride.Diabetes research and clinical practice · 1995
via PubMed
Article
7 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Interactions
- Mechanism of action
- Pharmacokinetics
- References
{{drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 412761821 | image = Glimepiride.svg | image_class = skin-invert-image | width = 300 | alt = | image2 = Glimepiride ball-and-stick model from xtal 1997.png | image_class2 = bg-transparent
| tradename = Amaryl, others | Drugs.com = | MedlinePlus = a696016 | DailyMedID = Glimepiride | pregnancy_AU = C | routes_of_administration = By mouth | ATC_prefix = A10 | ATC_suffix = BB12 | ATC_supplemental =